Efficacy and safety of 2 doses of agomelatine (10 mg/day or 25 mg/day) versus placebo in generalized anxiety disorder

被引：0

作者：

Stein, D. ^{[1
,2
]}

Ahokas, A. ^{[3
]}

Jarema, M. ^{[4
]}

Avedisova, A. S. ^{[5
]}

Vavrusova, L. ^{[6
]}

Chaban, O. ^{[7
]}

Olivier, V. ^{[8
]}

Gruget, C. ^{[8
]}

Picarel-Blanchot, F. ^{[8
]}

De Bodinat, C. ^{[8
]}

机构：

[1] Univ Cape Town, Cape Town, South Africa

[2] Mt Sinai Sch Med, Dept Psychiat, Cape Town, South Africa

[3] Mehilainen Clin, Dept Psychiat, Helsinki, Finland

[4] Ctr Terapii Dialog, Warsaw, Poland

[5] Psychiat Hosp 12, Moscow, Russia

[6] Univ Hosp Bratislava, Dept Psychiat, Bratislava, Slovakia

[7] Railway Clin Hosp, Psychoneurol Dept, Kiev, Ukraine

[8] Inst Rech Int Servier, Pole Innovat Therapeut Neuropsychiat, Suresnes, France

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2016年 / 26卷

关键词：

D O I：

10.1016/S0924-977X(16)31678-9

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P.4.b.003

引用

页码：S601 / S602

页数：2

共 50 条

[11] EFFICACY AND SAFETY OF 3 AGOMELATINE DOSE REGIMENS (10, 25, 25-50 MG) VERSUS PLACEBO IN OUT-PATIENTS SUFFERING FROM MODERATE TO SEVERE MAJOR DEPRESSIVE DISORDER [J].

Kennedy, S. H. ;

Avedisova, A. .

EUROPEAN PSYCHIATRY, 2013, 28

[12] Efficacy and Safety of Desvenlafaxine 25 and 50 Mg/Day in a Randomized, Placebo-Controlled Study of Depressed Outpatients [J].

Iwata, Nakao ;

Tourian, Karen A. ;

Hwang, Eunhee ;

Mele, Linda ;

Vialet, Cecile .

JOURNAL OF PSYCHIATRIC PRACTICE, 2013, 19 (01) :5-14

[13] SUSTAINED EFFICACY AND SAFETY OF AGOMELATINE 10, 25 AND 25-50MG VERSUS PLACEBO OVER 24 WEEKS IN OUT-PATIENTS SUFFERING FROM MODERATE TO SEVERE MAJOR DEPRESSIVE DISORDER [J].

Kennedy, S. H. ;

Avedisova, A. ;

Picarel, F. ;

De Bodinat, C. .

EUROPEAN PSYCHIATRY, 2014, 29

[14] Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies [J].

Dan J. Stein ;

Jon-Paul Khoo ;

Françoise Picarel-Blanchot ;

Valérie Olivier ;

Michael Van Ameringen .

Advances in Therapy, 2021, 38 :1567-1583

[15] Efficacy of agomelatine 25-50 mg in major depressive disorder [J].

Kennedy, S. H. ;

Olie, J. P. ;

Loo, H. ;

Emsley, R. .

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 :S231-S231

[16] Therapeutic efficacy and safety of oral tranexamic acid 250 mg once a day versus 500 mg twice a day: a comparative study [J].

Bhumika Chowdhary ;

Vikram K. Mahajan ;

Karaninder S. Mehta ;

Pushpinder S. Chauhan ;

Vikas Sharma ;

Anuj Sharma ;

Sanket Vashist ;

Prabal Kumar .

Archives of Dermatological Research, 2021, 313 :109-117

[17] Therapeutic efficacy and safety of oral tranexamic acid 250 mg once a day versus 500 mg twice a day: a comparative study [J].

Chowdhary, Bhumika ;

Mahajan, Vikram K. ;

Mehta, Karaninder S. ;

Chauhan, Pushpinder S. ;

Sharma, Vikas ;

Sharma, Anuj ;

Vashist, Sanket ;

Kumar, Prabal .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 2021, 313 (02) :109-117

[18] Efficacy of Agomelatine 25-50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies [J].

Stein, Dan J. ;

Khoo, Jon-Paul ;

Picarel-Blanchot, Francoise ;

Olivier, Valerie ;

Van Ameringen, Michael .

ADVANCES IN THERAPY, 2021, 38 (03) :1567-1583

[19] Sustained efficacy of agomelatine 10 mg, 25 mg, and 25-50 mg on depressive symptoms and functional outcomes in patients with major depressive disorder. A placebo-controlled study over 6 months [J].

Kennedy, Sidney H. ;

Avedisova, Alla ;

Belaidi, Carole ;

Picarel-Blanchot, Francoise ;

de Bodinat, Christian .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (02) :378-389

[20] CONTROLLED COMPARISON OF THE EFFICACY AND SAFETY OF 4 DOSES OF SURICLONE, DIAZEPAM, AND PLACEBO IN GENERALIZED ANXIETY DISORDER [J].

ANSSEAU, M ;

OLIE, JP ;

VONFRENCKELL, R ;

JOURDAIN, G ;

STEHLE, B ;

GUILLET, P .

PSYCHOPHARMACOLOGY, 1991, 104 (04) :439-443

← 1 2 3 4 5 →